Compounds > ketoprofen
Page last updated: 2024-10-29

ketoprofen and Rheumatoid Arthritis

ketoprofen has been researched along with Rheumatoid Arthritis in 117 studies

Ketoprofen: An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.
ketoprofen : An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"In doses of 1,200 mg/day or more, ibuprofen is as effective as aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of rheumatoid arthritis."10.15Update on ibuprofen for rheumatoid arthritis. ( Ward, JR, 1984)
"This study assessed the efficacy and safety of ketoprofen patch compared with placebo in patients who had rheumatoid arthritis and persistent wrist pain."9.14Efficacy and safety of ketoprofen patch in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study. ( Kawai, S; Kondo, M; Nagaya, I; Nawata, Y; Obata, J; Ohno, S; Oribe, M; Sugimoto, K; Uchida, E, 2010)
"The efficacy and tolerability of aceclofenac, a new non-steroidal anti-inflammatory drug (NSAID) was compared to that of ketoprofen in a multicentre, double-blind, prospective, randomized study of 3-months duration in patients with rheumatoid arthritis."9.08Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis. ( Ansoleaga, JJ; Gijón-Baños, J; Martín-Mola, E, 1995)
" Forty patients with rheumatoid arthritis were given either one intramuscular injection of 100 mg ketoprofen with two placebo capsules or one intramuscular injection of placebo with two 50 mg ketoprofen capsules."9.07[Comparative efficacy of ketoprofen related to the route of administration (intramuscular or per os). A double-blind study versus placebo in rheumatoid arthritis]. ( Amor, B; Dougados, M; Duchesne, L; Listrat, V, 1992)
" We therefore performed a double-blind comparative study of ketoprofen SR and sulindac in patients with active rheumatoid arthritis, 65 years of age or older."9.07A comparison of ketoprofen SR and sulindac in the elderly with rheumatoid arthritis. ( Ahern, MJ; James, RH; Leslie, A; Rennie, GC; Roberts-Thomson, PJ; Wetherall, M, 1992)
"The effects of three non-steroidal anti-inflammatory drugs (NSAIDs) on the pharmacokinetics of methotrexate were studied in 10 patients with rheumatoid arthritis."9.07Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis. ( Bradley, JD; Brater, DC; Greene, PK; Tracy, TS; Worster, T, 1994)
" Single oral doses of 100 mg racemic ketoprofen were given to 15 patients (age range: 51-79 years) with rheumatoid arthritis and a range of creatinine clearances (CLCR) from 26 to 159 ml min-1."9.07The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis. ( Ahern, MJ; Bochner, F; Hayball, PJ; Nation, RL; Sansom, LN; Smith, MD, 1993)
"A double-blind, double-dummy, crossover study was carried out in 8 centres to compare the efficacy and tolerability of 'controlled-release' ketoprofen tablets (200 mg) with that of indomethacin suppositories (100 mg) in out-patients with definite or classical rheumatoid arthritis."9.07A double-blind comparison of oral ketoprofen 'controlled release' and indomethacin suppository in the treatment of rheumatoid arthritis with special regard to morning stiffness and pain on awakening. ( Leden, I; Rubin, B; Uddenfeldt, P, 1993)
"The plasma and synovial fluid profiles of standard and controlled-release formulations of ketoprofen were compared in 8 patients with rheumatoid arthritis."9.06A comparison of plasma and synovial fluid profiles of standard and controlled-release formulations of ketoprofen in patients with rheumatoid arthritis. ( Boyd, MW; Kaye, CM; McCrea, JD; Telford, AM, 1986)
"Oral ketoprofen (200-300 mg/day) and indomethacin (100-150 mg/day) were compared in a 12-week double blind study involving 140 patients with rheumatoid arthritis."9.06Ketoprofen versus indomethacin in patients with rheumatoid arthritis: a multicenter double blind comparative study. ( Caldwell, JR; Germain, BF; Lourie, SH; McLaughlin, GE; Poiley, JE; Vreede, PD; Wilson, CH, 1988)
"38 patients with active rheumatoid arthritis, randomly divided into two groups, underwent a three weeks treatment with profenid (3 capsules + 1 suppositorium) alternatively with indomethacin (3 capsules + 1 suppositorium), which head lasted six weeks in case of each patient."9.05[Comparative crossover double-blind study of profenid and indomethacin patients with rheumatoid arthritis]. ( Dyczek-Parys, E; Gabryel, A; Gałaszek, Z; Jonderko, G; Nowicki, L; Szczesny-Siwinski, H, 1982)
"The efficacy and tolerance of pirprofen and ketoprofen in rheumatoid arthritis were compared in a cooperative, double-blind, cross-over trial involving 124 patients."9.05[Pirprofen in the treatment of rheumatoid arthritis]. ( Ayrolles, C; Fournie, A, 1982)
"Forty-seven patients with active rheumatoid arthritis took part in an 8-week controlled study in which clotrimazole was compared with a standard nonsteroidal anti-inflammatory agent, ketoprofen."9.05Clotrimazole in rheumatoid arthritis. ( Gibson, T; Gow, PJ; Grahame, R; Mason, J; Panayi, GS; Walter, J; Wojtulewski, JA, 1980)
"A double-blind cross-over study is being undertaken in fifty patients with "definite" rheumatoid arthritis, comparing ketoprofen (2-(3-phenylbenzoyl proprionic acid) 75 mg daily orally and 100 mg suppository at night with indomethacin in the same dosage."9.04Ketoprofen: double-blind cross-over study with indomethacin administered as a combined suppository/capsule regime in patients with rheumatoid arthritis. A preliminary report. ( Bloch, M; Gibson, T; Grahame, R; Griffin, AJ, 1978)
"The tolerance of ketoprofen (2-(3-benzoylphenyl)-propionic acid) was studied in sixteen patients with rheumatoid arthritis during a treatment period up to seven months."9.04Long-term treatment with ketoprofen in rheumatoid arthritis. A clinical trial with special reference to side-effects. ( Peltola, P, 1976)
"A two-week double-blind crossover study of ketoprofen, a non-steroidal antiinflammatory agent, and placebo was done in ten patients with active rheumatoid arthritis in order to obtain a preliminary efficacy estimate of this new drug."9.04A double-blind crossover evaluation of ketoprofen (Orudis) and placebo in rheumatoid arthritis with assessment of long-term tolerance. ( Howard, DL, 1978)
"Twenty-three patients with rheumatoid arthritis participated in a double-blind crossover investigation of ketoprofen (Orudis) and indomethacin."9.04A double-blind crossover comparison of Orudis (ketoprofen) and indomethacin in the treatment of rheumatoid arthritis. ( Digby, JW; Wehner, S, 1976)
"In a multi-centre double-blind cross-over trial using the double-placebo technique, 55 patients with rheumatoid arthritis were treated for 10 days for each trial drug with ketoprofen (200 mg/day) and ibuprofen (1200 mg/day)."9.04A double-blind cross-over evaluation of ketoprofen (Orudis) and ibuprofen in the management of rheumatoid arthritis. ( Fumagalli, M; Liverta, C; Montrone, F; Pellegrini, P; Pollini, C; Pontiroli, AE; Ratti, G; Sala, G, 1979)
"A double-blind parallel multi-centre study of 102 patients with rheumatoid arthritis (RA) was performed, comparing ibuprofen (1200-2400 mg daily) and ketoprofen (150-300 mg daily) a new non-steroidal, anti-inflammatory agent, over a three month period."9.04Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis. ( Bennett, RM; Calin, A; Giuliano, VJ; Goldman, AL; Montoya, HE; O'Brien, WM; Sakofsky, HY; Schmid, FR; Sukhupunyaraksa, S; Willkens, RF, 1977)
"In a double-blind cross-over trial, ketoprofen was found to be as effective as indomethacin in the treatment of rheumatoid arthritis."9.04Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis: a double-blind cross-over comparison with indomethacin. ( Fossgreen, J; Kirchheiner, B; Tophoj, E; Zachariae, E, 1976)
"In a double-blind cross-over trial in rheumatoid arthritis, no difference was found between ketoprofen and phenylbutazone with regard to clinical efficacy at the dosages used."9.04Clinical evaluation of keto profen (Orudis) in rheumatoid arthritis: results of a multi-centre double-blind trial against phenylbutazone. ( Brath, HK; Haerum, LB; Straume, S; Sydnes, OA, 1976)
"A double-blind cross-over trial of ketoprofen (200 mg daily) compared with placebo and aspirin (4 g daily) was carried out in 24 patients with rheumatoid arthritis."9.04Ketoprofen in the treatment of rheumatoid arthritis. ( Kennedy, AC, 1976)
"A 4-weeks' double-blind, crossover study in 30 patients with definite or classical rheumatoid arthritis is reported using 300 mg ketoprofen per day and 150 mg indomethacin per day."9.04A comparative trial of large doses of ketoprofen and indomethacin in the treatment of rheumatoid arthritis. ( El-Ghobarey, AF; Hadidi, T; Hamid, HA; Mavrikakis, M; Rennie, JA, 1976)
"), in comparison with that of indomethacin was investigated in 30 patients with rheumatoid arthritis."9.04Clinical evaluation of ketoprofen (19.583 R.P.) in rheumatoid arthritis. Double-blind cross-over comparison with indomethacin. ( Fossgreen, J; Kirchheiner, B; Petersen, FO; Tophoj, E; Zachariae, E, 1976)
"In a multi-centre, double-blind, cross-over trial comprising 38 patients with rheumatoid arthritis, ketoprofen was given at a dosage of 150 mg daily and phenylbutazone at a dosage of 300 mg daily, each for 2 weeks."9.04Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis. Results of a multi-centre, double-blind, cross-over trial against phenylbutazone. ( Brath, HK; Haerum, LB; Straume, S; Sydnes, O, 1976)
"A double-blind cross-over trial was carried out in 50 patients with definite rheumatoid arthritis, in order to compare the effects of 300 mg/day of ketoprofen with those of 600 mg/day of phenylbutazone, e."9.04A double-blind cross-over study of ketoprofen and phenylbutazone in rheumatoid arthritis. ( Peltola, P, 1976)
"Pharmacokinetics of ketoprofen (KTP) enantiomers has been studied in patients with rheumatoid arthritis (RA) following administration of a single oral dose of 100 mg rac-KTP during multidrug therapy taking into consideration the genotype of RA patients Concentrations of (-)-R and (+)-S enantiomers of KTP in plasma, urine and synovial fluid samples were determined using a validated HPCE method."7.77Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis. ( Grześkowiak, E; Główka, F; Karaźniewicz-Łada, M; Rogozinska, D; Romanowski, W, 2011)
"Thirty-one hospital outpatients in Thailand, 14 with rheumatoid arthritis and 17 with osteoarthritis, received 100 mg (15 patients) or 200 mg (16 patients) of controlled-release ketoprofen daily for 12 weeks."7.67Controlled-release ketoprofen in rheumatoid arthritis and osteoarthritis: comparison of two doses in Thailand. ( Chivabongs, A, 1988)
"Ketoprofen (Orudis) in doses of 100-200 mg daily was given to 11 patients with rheumatoid arthritis and 14 patients with osteoarthritis."7.65A study of ketoprofen (Orudis) in the treatment of rheumatoid arthritis and osteoarthrosis. ( Akram, G; Hassan, NW; Jabeen, S, 1976)
"Ketoprofen was preferred more often by the patients while the investigator found it acceptable as often as aspirin."6.64A double-blind cross-over evaluation of ketoprofen and aspirin in rheumatoid arthritis. ( Camerlain, M; Lussier, A; Menard, H; Myhal, D; Wehner, S, 1976)
"In doses of 1,200 mg/day or more, ibuprofen is as effective as aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of rheumatoid arthritis."6.15Update on ibuprofen for rheumatoid arthritis. ( Ward, JR, 1984)
" Pharmacokinetic parameters following the first dose including Tmax which was 6."5.27Acute and chronic pharmacokinetic studies of slow release ketoprofen (Oruvail) in rheumatoid arthritis. ( Christophidis, N; Louis, WJ; Rotstein, A, 1986)
"This study assessed the efficacy and safety of ketoprofen patch compared with placebo in patients who had rheumatoid arthritis and persistent wrist pain."5.14Efficacy and safety of ketoprofen patch in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study. ( Kawai, S; Kondo, M; Nagaya, I; Nawata, Y; Obata, J; Ohno, S; Oribe, M; Sugimoto, K; Uchida, E, 2010)
"The efficacy and tolerability of aceclofenac, a new non-steroidal anti-inflammatory drug (NSAID) was compared to that of ketoprofen in a multicentre, double-blind, prospective, randomized study of 3-months duration in patients with rheumatoid arthritis."5.08Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis. ( Ansoleaga, JJ; Gijón-Baños, J; Martín-Mola, E, 1995)
" We therefore performed a double-blind comparative study of ketoprofen SR and sulindac in patients with active rheumatoid arthritis, 65 years of age or older."5.07A comparison of ketoprofen SR and sulindac in the elderly with rheumatoid arthritis. ( Ahern, MJ; James, RH; Leslie, A; Rennie, GC; Roberts-Thomson, PJ; Wetherall, M, 1992)
"The effects of three non-steroidal anti-inflammatory drugs (NSAIDs) on the pharmacokinetics of methotrexate were studied in 10 patients with rheumatoid arthritis."5.07Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis. ( Bradley, JD; Brater, DC; Greene, PK; Tracy, TS; Worster, T, 1994)
"A double-blind, double-dummy, crossover study was carried out in 8 centres to compare the efficacy and tolerability of 'controlled-release' ketoprofen tablets (200 mg) with that of indomethacin suppositories (100 mg) in out-patients with definite or classical rheumatoid arthritis."5.07A double-blind comparison of oral ketoprofen 'controlled release' and indomethacin suppository in the treatment of rheumatoid arthritis with special regard to morning stiffness and pain on awakening. ( Leden, I; Rubin, B; Uddenfeldt, P, 1993)
" Forty patients with rheumatoid arthritis were given either one intramuscular injection of 100 mg ketoprofen with two placebo capsules or one intramuscular injection of placebo with two 50 mg ketoprofen capsules."5.07[Comparative efficacy of ketoprofen related to the route of administration (intramuscular or per os). A double-blind study versus placebo in rheumatoid arthritis]. ( Amor, B; Dougados, M; Duchesne, L; Listrat, V, 1992)
" Single oral doses of 100 mg racemic ketoprofen were given to 15 patients (age range: 51-79 years) with rheumatoid arthritis and a range of creatinine clearances (CLCR) from 26 to 159 ml min-1."5.07The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis. ( Ahern, MJ; Bochner, F; Hayball, PJ; Nation, RL; Sansom, LN; Smith, MD, 1993)
"Oral ketoprofen (200-300 mg/day) and indomethacin (100-150 mg/day) were compared in a 12-week double blind study involving 140 patients with rheumatoid arthritis."5.06Ketoprofen versus indomethacin in patients with rheumatoid arthritis: a multicenter double blind comparative study. ( Caldwell, JR; Germain, BF; Lourie, SH; McLaughlin, GE; Poiley, JE; Vreede, PD; Wilson, CH, 1988)
"The plasma and synovial fluid profiles of standard and controlled-release formulations of ketoprofen were compared in 8 patients with rheumatoid arthritis."5.06A comparison of plasma and synovial fluid profiles of standard and controlled-release formulations of ketoprofen in patients with rheumatoid arthritis. ( Boyd, MW; Kaye, CM; McCrea, JD; Telford, AM, 1986)
"38 patients with active rheumatoid arthritis, randomly divided into two groups, underwent a three weeks treatment with profenid (3 capsules + 1 suppositorium) alternatively with indomethacin (3 capsules + 1 suppositorium), which head lasted six weeks in case of each patient."5.05[Comparative crossover double-blind study of profenid and indomethacin patients with rheumatoid arthritis]. ( Dyczek-Parys, E; Gabryel, A; Gałaszek, Z; Jonderko, G; Nowicki, L; Szczesny-Siwinski, H, 1982)
"Forty-seven patients with active rheumatoid arthritis took part in an 8-week controlled study in which clotrimazole was compared with a standard nonsteroidal anti-inflammatory agent, ketoprofen."5.05Clotrimazole in rheumatoid arthritis. ( Gibson, T; Gow, PJ; Grahame, R; Mason, J; Panayi, GS; Walter, J; Wojtulewski, JA, 1980)
" Effectiveness of the two forms of ketoprofen on morning stiffness and pain scale was found to be comparable."5.05[Double-blind comparative study of Bi-Profenid tablets and Profenid capsules in inflammatory rheumatism]. ( Ayrolles, C; Camus, JP; Fournie, A; Koeger, AC; Prier, A, 1983)
"The efficacy and tolerance of pirprofen and ketoprofen in rheumatoid arthritis were compared in a cooperative, double-blind, cross-over trial involving 124 patients."5.05[Pirprofen in the treatment of rheumatoid arthritis]. ( Ayrolles, C; Fournie, A, 1982)
"Ketoprofen (100 mg/day) and indomethacin (100 mg/day) were compared in a double-blind cross-over trial of four weeks duration in 46 patients with rheumatoid arthritis."5.04Ketoprofen -- a new anti-rheumatic agent. ( Burry, HC; Grahame, R, 1976)
"In a multi-centre double-blind cross-over trial using the double-placebo technique, 55 patients with rheumatoid arthritis were treated for 10 days for each trial drug with ketoprofen (200 mg/day) and ibuprofen (1200 mg/day)."5.04A double-blind cross-over evaluation of ketoprofen (Orudis) and ibuprofen in the management of rheumatoid arthritis. ( Fumagalli, M; Liverta, C; Montrone, F; Pellegrini, P; Pollini, C; Pontiroli, AE; Ratti, G; Sala, G, 1979)
"), in comparison with that of indomethacin was investigated in 30 patients with rheumatoid arthritis."5.04Clinical evaluation of ketoprofen (19.583 R.P.) in rheumatoid arthritis. Double-blind cross-over comparison with indomethacin. ( Fossgreen, J; Kirchheiner, B; Petersen, FO; Tophoj, E; Zachariae, E, 1976)
"A 4-weeks' double-blind, crossover study in 30 patients with definite or classical rheumatoid arthritis is reported using 300 mg ketoprofen per day and 150 mg indomethacin per day."5.04A comparative trial of large doses of ketoprofen and indomethacin in the treatment of rheumatoid arthritis. ( El-Ghobarey, AF; Hadidi, T; Hamid, HA; Mavrikakis, M; Rennie, JA, 1976)
"A double-blind cross-over trial of ketoprofen (200 mg daily) compared with placebo and aspirin (4 g daily) was carried out in 24 patients with rheumatoid arthritis."5.04Ketoprofen in the treatment of rheumatoid arthritis. ( Kennedy, AC, 1976)
"In a double-blind cross-over trial in rheumatoid arthritis, no difference was found between ketoprofen and phenylbutazone with regard to clinical efficacy at the dosages used."5.04Clinical evaluation of keto profen (Orudis) in rheumatoid arthritis: results of a multi-centre double-blind trial against phenylbutazone. ( Brath, HK; Haerum, LB; Straume, S; Sydnes, OA, 1976)
"Twenty-three patients with rheumatoid arthritis participated in a double-blind crossover investigation of ketoprofen (Orudis) and indomethacin."5.04A double-blind crossover comparison of Orudis (ketoprofen) and indomethacin in the treatment of rheumatoid arthritis. ( Digby, JW; Wehner, S, 1976)
"The tolerance of ketoprofen (2-(3-benzoylphenyl)-propionic acid) was studied in sixteen patients with rheumatoid arthritis during a treatment period up to seven months."5.04Long-term treatment with ketoprofen in rheumatoid arthritis. A clinical trial with special reference to side-effects. ( Peltola, P, 1976)
"A double-blind parallel multi-centre study of 102 patients with rheumatoid arthritis (RA) was performed, comparing ibuprofen (1200-2400 mg daily) and ketoprofen (150-300 mg daily) a new non-steroidal, anti-inflammatory agent, over a three month period."5.04Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis. ( Bennett, RM; Calin, A; Giuliano, VJ; Goldman, AL; Montoya, HE; O'Brien, WM; Sakofsky, HY; Schmid, FR; Sukhupunyaraksa, S; Willkens, RF, 1977)
"A two-week double-blind crossover study of ketoprofen, a non-steroidal antiinflammatory agent, and placebo was done in ten patients with active rheumatoid arthritis in order to obtain a preliminary efficacy estimate of this new drug."5.04A double-blind crossover evaluation of ketoprofen (Orudis) and placebo in rheumatoid arthritis with assessment of long-term tolerance. ( Howard, DL, 1978)
"A double-blind cross-over study is being undertaken in fifty patients with "definite" rheumatoid arthritis, comparing ketoprofen (2-(3-phenylbenzoyl proprionic acid) 75 mg daily orally and 100 mg suppository at night with indomethacin in the same dosage."5.04Ketoprofen: double-blind cross-over study with indomethacin administered as a combined suppository/capsule regime in patients with rheumatoid arthritis. A preliminary report. ( Bloch, M; Gibson, T; Grahame, R; Griffin, AJ, 1978)
"In a double-blind cross-over trial, ketoprofen was found to be as effective as indomethacin in the treatment of rheumatoid arthritis."5.04Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis: a double-blind cross-over comparison with indomethacin. ( Fossgreen, J; Kirchheiner, B; Tophoj, E; Zachariae, E, 1976)
"Ninety patients with rheumatoid arthritis completed a double-blind crossover trial comparing fenoprofen, ibuprofen, ketoprofen, and naproxen."5.04Four new anti-inflammatory drugs: responses and variations. ( Balme, HW; Franklin, S; Huskisson, EC; Scott, J; Woolf, DL, 1976)
"A double-blind cross-over trial was carried out in 50 patients with definite rheumatoid arthritis, in order to compare the effects of 300 mg/day of ketoprofen with those of 600 mg/day of phenylbutazone, e."5.04A double-blind cross-over study of ketoprofen and phenylbutazone in rheumatoid arthritis. ( Peltola, P, 1976)
"In a multi-centre, double-blind, cross-over trial comprising 38 patients with rheumatoid arthritis, ketoprofen was given at a dosage of 150 mg daily and phenylbutazone at a dosage of 300 mg daily, each for 2 weeks."5.04Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis. Results of a multi-centre, double-blind, cross-over trial against phenylbutazone. ( Brath, HK; Haerum, LB; Straume, S; Sydnes, O, 1976)
"There is good evidence that some formulations of topical diclofenac and ketoprofen are useful in acute pain conditions such as sprains or strains, with low (good) NNT values."4.95Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews. ( Aldington, D; Bell, RF; Derry, S; Gaskell, H; Kalso, EA; Moore, RA; Phillips, T; Wiffen, PJ, 2017)
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."4.21 ( Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022)
"Ketoprofen, a non-steroid anti-inflammatory drug, is widely used for relieving the pain and swelling caused by rheumatoid arthritis."3.88Ketoprofen and MicroRNA-124 Co-loaded poly (lactic-co-glycolic acid) microspheres inhibit progression of Adjuvant-induced arthritis in rats. ( Lee, RJ; Li, X; Li, Y; Liu, J; Liu, N; Long, C; Sun, F; Sun, X; Teng, L; Yu, C; Zhang, X, 2018)
" In this study, we prepared novel topical formulations containing ketoprofen (KET) solid nanoparticles (KETnano gel ointment) and investigated the antiinflammatory effect of the KET nanoparticle formulations on rheumatoid arthritis using adjuvant-induced arthritis (AA) rats."3.81Pharmacokinetics and Antiinflammatory Effect of a Novel Gel System Containing Ketoprofen Solid Nanoparticles. ( Ito, Y; Iwamae, A; Nagai, N; Tanimoto, S; Yoshioka, C, 2015)
"Pharmacokinetics of ketoprofen (KTP) enantiomers has been studied in patients with rheumatoid arthritis (RA) following administration of a single oral dose of 100 mg rac-KTP during multidrug therapy taking into consideration the genotype of RA patients Concentrations of (-)-R and (+)-S enantiomers of KTP in plasma, urine and synovial fluid samples were determined using a validated HPCE method."3.77Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis. ( Grześkowiak, E; Główka, F; Karaźniewicz-Łada, M; Rogozinska, D; Romanowski, W, 2011)
"The aim of this study was to develop a pH-responsive dual pulse multiparticulate dosage form containing a model drug ketoprofen, a nonsteroidal anti-inflammatory drug used for rheumatoid arthritis."3.76pH-responsive dual pulse multiparticulate dosage form for treatment of rheumatoid arthritis. ( Kadam, V; Kedar, U; Lotlikar, V; Shidhaye, S, 2010)
" In this study, the effects of M-5011 on arachidonic acid (AA) metabolism in synovial fibroblasts from patients with rheumatoid arthritis were evaluated and compared with those of other NSAIDs in vitro."3.69The effects of a newly developed nonsteroidal anti-inflammatory drug (M-5011) on arachidonic acid metabolism in rheumatoid synovial fibroblasts. ( Ando, T; Himeno, M; Kataoka, M; Sugimoto, K; Tobetto, K; Yamamoto, Y, 1997)
"Thirty-one hospital outpatients in Thailand, 14 with rheumatoid arthritis and 17 with osteoarthritis, received 100 mg (15 patients) or 200 mg (16 patients) of controlled-release ketoprofen daily for 12 weeks."3.67Controlled-release ketoprofen in rheumatoid arthritis and osteoarthritis: comparison of two doses in Thailand. ( Chivabongs, A, 1988)
"The anti-inflammatory effects of ketoprofen (Alrheumat) in inflamed areas are achieved by antagonizing inflammation mediators or blocking their synthesis."3.66The pharmacological properties of ketoprofen and its place in antirheumatic therapy. ( Kaller, H, 1979)
"Serum and synovial fluid concentrations of ketoprofen were studied after administration of 50 or 100 mg in a single oral dose to patients with rheumatoid arthritis."3.66[Pharmacokinetics of ketoprofen in the synovial fluid]. ( Kennedy, AC, 1983)
" In addition, the effect of clotrimazole on in vitro mitogenic responsiveness of lymphocytes of a group of patients with rheumatoid arthritis taking this drug was compared to that of the proprionic acid derivative, ketoprofen."3.66The effect of clotrimazole on human lymphocyte responsiveness to plant mitogens. ( Corrigall, V; Gow, PJ; Panayi, GS, 1979)
"The therapeutic value of non-steroid anti-inflammatory agents for therapy of rheumatoid arthritis is discussed and a long-term study is described which was carried out for up to 12 monts on tolerance of ketoprofen compared with indomethacin."3.66Long-term studies on therapy and tolerance of ketoprofen. ( Gross, W, 1979)
"Ketoprofen (Orudis) in doses of 100-200 mg daily was given to 11 patients with rheumatoid arthritis and 14 patients with osteoarthritis."3.65A study of ketoprofen (Orudis) in the treatment of rheumatoid arthritis and osteoarthrosis. ( Akram, G; Hassan, NW; Jabeen, S, 1976)
"A study was made of the plasma and synovial-fluid levels of ketoprofen after single oral doses of 50 mg and 100 mg given to patients with rheumatoid arthritis."3.65Synovial-fluid pharmacokinetics of ketoprofen. ( Kennedy, AC, 1976)
" In the carrageenan edema test, eight compounds exhibited higher antiinflammatory activities than did indomethacin."3.656,11-Dihydro-11-oxodibenz [b,e] oxepinacetic acids with potent antiinflammatory activity. ( Kubo, S; Tagawa, H; Tsukada, W; Ueno, K; Yoshioka, T, 1976)
"5 mg/kg CyA/day and dosage was increased cautiously to 5 mg/kg/day or less if the serum creatinine rose by > or = 30% above baseline."2.68Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs. ( Baker, P; Bensen, W; Gent, M; Grace, E; Ludwin, D; Roberts, R; Tugwell, P, 1997)
" No significant differences in CL/F, area under the curve (AUC), half-life (t1/2), time to reach peak concentration (tmax), or maximum peak plasma concentration (Cmax) were found between groups or between doses, and values were similar to those previously reported in young adults."2.67Ketoprofen pharmacokinetics in the elderly: influence of rheumatic disease, renal function, and dose. ( Jamali, F; Russell, AS; Skeith, KJ, 1993)
" Dosage convenience, effectiveness on pain during the second part of the night and resolution of morning stiffness were considered better with Bi-Profenid by 23 patients and with conventional forms by four, while five reported no preference."2.65[Open clinical trial of a new oral galenic form of ketoprofen]. ( Asch, L; Huck, F; Kuntz, JL; Lecocq, J; Meyer, R, 1983)
" The authors conclude that Bi-Profenid is effective at a daily dosage of 150 mg, thus enabling to adjust prescriptions to actual needs when pain is not continuous throughout the 24 hours."2.65[Double-blind comparative study of slow-release ketoprofen and a placebo in chronic inflammatory rheumatism]. ( Amor, B; Harrewyn, JM, 1983)
"Preliminary results are reported on 30 patients treated with suppositories of ketoprofen at a dosage of two daily (200 mg)."2.64Ketoprofen suppositories in rheumatological practice. ( Blotman, F; Simon, L, 1976)
"Ketoprofen was preferred more often by the patients while the investigator found it acceptable as often as aspirin."2.64A double-blind cross-over evaluation of ketoprofen and aspirin in rheumatoid arthritis. ( Camerlain, M; Lussier, A; Menard, H; Myhal, D; Wehner, S, 1976)
" Pharmacokinetic parameters following the first dose including Tmax which was 6."1.27Acute and chronic pharmacokinetic studies of slow release ketoprofen (Oruvail) in rheumatoid arthritis. ( Christophidis, N; Louis, WJ; Rotstein, A, 1986)
" The dosage has to be established individually for each patient because the resorption is independent from body size and body weight."1.26[Distribution of non-steroidal anti-inflammatory agents in human tissues]. ( Köhler, G, 1982)

Research

Studies (117)

TimeframeStudies, this research(%)All Research%
pre-199087 (74.36)18.7374
1990's15 (12.82)18.2507
2000's2 (1.71)29.6817
2010's10 (8.55)24.3611
2020's3 (2.56)2.80

Authors

AuthorsStudies
Ueno, K1
Kubo, S1
Tagawa, H1
Yoshioka, T1
Tsukada, W1
Akgul, O1
Di Cesare Mannelli, L2
Vullo, D1
Angeli, A1
Ghelardini, C2
Bartolucci, G2
Alfawaz Altamimi, AS1
Scozzafava, A1
Supuran, CT2
Carta, F2
Bua, S1
Lucarini, L1
Micheli, L1
Menicatti, M1
Selleri, S1
Masini, E1
Gratteri, P1
Nocentini, A1
Nese, M1
Riboli, G1
Brighetti, G1
Sassi, V1
Camela, E1
Caselli, G1
Sassaroli, S1
Borlimi, R1
Aucoin, M1
Cooley, K1
Saunders, PR1
Carè, J1
Anheyer, D1
Medina, DN1
Cardozo, V1
Remy, D1
Hannan, N1
Garber, A1
Velayos, M1
Muñoz-Serrano, AJ1
Estefanía-Fernández, K1
Sarmiento Caldas, MC1
Moratilla Lapeña, L1
López-Santamaría, M1
López-Gutiérrez, JC1
Li, J1
Zhang, J1
Shen, S1
Zhang, B2
Yu, WW1
Toyoda, H1
Huang, DQ1
Le, MH1
Nguyen, MH1
Huang, R1
Zhu, L1
Wang, J6
Xue, L1
Liu, L2
Yan, X2
Huang, S1
Li, Y8
Xu, T1
Li, C2
Ji, F1
Ming, F1
Zhao, Y2
Cheng, J1
Wang, Y3
Zhao, H1
Hong, S1
Chen, K2
Zhao, XA1
Zou, L1
Sang, D1
Shao, H1
Guan, X1
Chen, X2
Chen, Y4
Wei, J1
Zhu, C1
Wu, C1
Moore, HB1
Barrett, CD1
Moore, EE1
Jhunjhunwala, R1
McIntyre, RC1
Moore, PK1
Hajizadeh, N1
Talmor, DS1
Sauaia, A1
Yaffe, MB1
Liu, C3
Lin, Y1
Dong, Y1
Wu, Y1
Bao, Y1
Yan, H2
Ma, J1
Fernández-Cuadros, ME1
Albaladejo-Florín, MJ1
Álava-Rabasa, S1
Usandizaga-Elio, I1
Martinez-Quintanilla Jimenez, D1
Peña-Lora, D1
Neira-Borrajo, I1
López-Muñoz, MJ1
Rodríguez-de-Cía, J1
Pérez-Moro, OS1
Abdallah, M1
Alsaleh, H1
Baradwan, A1
Alfawares, R1
Alobaid, A1
Rasheed, A1
Soliman, I1
Wendel Garcia, PD1
Fumeaux, T1
Guerci, P1
Heuberger, DM1
Montomoli, J2
Roche-Campo, F1
Schuepbach, RA1
Hilty, MP1
Poloni, TE1
Carlos, AF1
Cairati, M1
Cutaia, C1
Medici, V1
Marelli, E1
Ferrari, D1
Galli, A1
Bognetti, P1
Davin, A1
Cirrincione, A1
Ceretti, A1
Cereda, C1
Ceroni, M1
Tronconi, L1
Vitali, S1
Guaita, A1
Leeds, JS1
Raviprakash, V1
Jacques, T1
Scanlon, N1
Cundall, J1
Leeds, CM1
Riva, A1
Gray, EH1
Azarian, S1
Zamalloa, A1
McPhail, MJW1
Vincent, RP1
Williams, R1
Chokshi, S1
Patel, VC1
Edwards, LA1
Alqarawi, W1
Birnie, DH1
Golian, M1
Nair, GM1
Nery, PB1
Klein, A1
Davis, DR1
Sadek, MM1
Neilipovitz, D1
Johnson, CB1
Green, MS1
Redpath, C1
Miller, DC1
Beamer, P1
Billheimer, D1
Subbian, V1
Sorooshian, A1
Campbell, BS1
Mosier, JM1
Novaretti, JV1
Astur, DC1
Cavalcante, ELB1
Kaleka, CC1
Amaro, JT1
Cohen, M1
Huang, W1
Li, T1
Ling, Y1
Qian, ZP1
Zhang, YY1
Huang, D1
Xu, SB1
Liu, XH1
Xia, L1
Yang, Y3
Lu, SH1
Lu, HZ1
Zhang, R2
Ma, JX1
Tang, S1
Li, CM1
Wan, J1
Wang, JF1
Ma, JQ1
Luo, JJ1
Chen, HY2
Mi, SL1
Chen, SY1
Su, YG1
Ge, JB1
Milheiro, SA1
Gonçalves, J1
Lopes, RMRM1
Madureira, M1
Lobo, L1
Lopes, A1
Nogueira, F1
Fontinha, D1
Prudêncio, M1
M Piedade, MF1
Pinto, SN1
Florindo, PR1
Moreira, R1
Castillo-Lora, J1
Delley, MF1
Laga, SM1
Mayer, JM1
Sutjarit, N1
Thongon, N1
Weerachayaphorn, J1
Piyachaturawat, P1
Suksamrarn, A1
Suksen, K1
Papachristou, DJ1
Blair, HC1
Hu, Y1
Shen, P1
Zeng, N1
Wang, L3
Yan, D1
Cui, L1
Yang, K2
Zhai, C1
Yang, M1
Lao, X1
Sun, J1
Ma, N1
Wang, S1
Ye, W1
Guo, P1
Rahimi, S1
Singh, MP1
Gupta, J1
Nakanishi, I1
Ohkubo, K1
Shoji, Y1
Fujitaka, Y1
Shimoda, K1
Matsumoto, KI1
Fukuhara, K1
Hamada, H1
van der Boom, T1
Gruppen, EG1
Lefrandt, JD1
Connelly, MA1
Links, TP1
Dullaart, RPF1
Berry, JD1
Bedlack, R1
Mathews, D1
Agnese, W1
Apple, S1
Meloncelli, S1
Divizia, M1
Germani, G1
Adefegha, SA1
Bottari, NB1
Leal, DB1
de Andrade, CM1
Schetinger, MR1
Martínez-Velasco, A1
Perez-Ortiz, AC1
Antonio-Aguirre, B1
Martínez-Villaseñor, L1
Lira-Romero, E1
Palacio-Pastrana, C1
Zenteno, JC1
Ramirez, I1
Zepeda-Palacio, C1
Mendoza-Velásquez, C1
Camacho-Ordóñez, A1
Ortiz Bibriesca, DM1
Estrada-Mena, FJ1
Martin, BL1
Thompson, LC1
Kim, YH2
Snow, SJ1
Schladweiler, MC1
Phillips, P1
Harmon, M1
King, C1
Richards, J1
George, I1
Haykal-Coates, N1
Gilmour, MI1
Kodavanti, UP1
Hazari, MS1
Farraj, AK1
Shen, Z1
Zou, Y1
Gao, K1
Lazar, S1
Wurtzel, JGT1
Ma, P1
Goldfinger, LE1
Vukelic, M1
Laloo, A1
Kyttaris, VC1
Chen, R1
Chen, J2
Xun, J1
Hu, Z1
Huang, Q2
Steinhart, C1
Shen, Y1
Lu, H1
Mansuri, A1
Lokhande, K1
Kore, S1
Gaikwad, S1
Nawani, N1
Swamy, KV1
Junnarkar, M1
Pawar, S1
Shaheen, MY1
Basudan, AM1
Niazy, AA1
van den Beucken, JJJP1
Jansen, JA1
Alghamdi, HS1
Gao, Q2
Guo, X1
Cao, Y1
Jia, X1
Xu, S1
Lu, C2
Zhu, H2
Melku, M1
Abebe, G1
Teketel, A1
Asrie, F1
Yalew, A1
Biadgo, B1
Kassa, E1
Damtie, D1
Anlay, DZ1
Ahmed, MFE1
Ramadan, H1
Seinige, D1
Kehrenberg, C1
Abd El-Wahab, A1
Volkmann, N1
Kemper, N1
Schulz, J1
Hu, MY1
Wu, YN1
McEvoy, MP1
Wang, YF1
Cong, WL1
Liu, LP1
Li, XX1
Zhou, CL1
Chen, WM1
Wei, KL1
Tung, SY1
Shen, CH1
Chang, TS1
Yen, CW1
Hsieh, YY1
Chiu, WN1
Hu, JH1
Lu, SN1
Hung, CH1
Alakavuklar, MA1
Fuqua, C1
Luo, KL1
Underwood, RS1
Greenwald, I1
Elashiry, MM1
Elashiry, M1
Zeitoun, R1
Elsayed, R1
Tian, F1
Saber, SE1
Elashry, SH1
Tay, FR1
Cutler, CW1
O'Dowd, A1
Maciel, M1
Poole, ST1
Jobling, MG1
Rollenhagen, JE1
Woods, CM1
Sincock, SA1
McVeigh, AL1
Gregory, MJ1
Maves, RC1
Prouty, MG1
Holmes, RK1
Savarino, SJ1
Mor, MK1
Palevsky, PM1
Kaufman, JS1
Thiessen Philbrook, H1
Weisbord, SD1
Parikh, CR1
John, CM1
Phillips, NJ1
Jarvis, GA1
Zhu, Y1
Kilburn, S1
Kapoor, M1
Chaturvedi, S1
Shaw, KJ1
Chaturvedi, V1
Kong, X1
Zhang, T1
Xiao, H1
Feng, X1
Tu, H1
Feng, J1
Sabet, M1
Tarazi, Z1
Griffith, DC1
Nguyen, F1
Guan, P1
Guerrero, DT1
Kolla, V1
Naraparaju, K1
Perry, LM1
Soberman, D1
Pressly, BB1
Alferiev, IS1
Chorny, M1
Brodeur, GM1
Gao, X2
Cheng, YH1
Enten, GA1
DeSantis, AJ1
Gaponenko, V1
Majetschak, M1
Kim, DY1
Choi, MJ1
Ko, TK1
Lee, NH1
Kim, OH1
Cheon, HG1
Cai, H1
Yip, V1
Lee, MV1
Wong, S1
Saad, O1
Ma, S1
Ljumanovic, N1
Khojasteh, SC1
Kamath, AV1
Shen, BQ1
Cuypers, ML1
Chanteux, H1
Gillent, E1
Bonnaillie, P1
Saunders, K1
Beckers, C1
Delatour, C1
Dell'Aiera, S1
Ungell, AL1
Nicolaï, J1
Knapp, AK1
Chen, A1
Griffin-Nolan, RJ1
Baur, LE1
Carroll, CJW1
Gray, JE1
Hoffman, AM1
Li, X5
Post, AK1
Slette, IJ1
Collins, SL1
Luo, Y1
Smith, MD2
Temitayo, GI1
Olawande, B1
Emmanuel, YO1
Timothy, AT1
Kehinde, O1
Susan, LF1
Ezra, L1
Joseph, OO1
Lev, S1
Desmarini, D1
Liuwantara, D1
Sorrell, TC1
Hawthorne, WJ1
Djordjevic, JT1
Verso, MG1
Costantino, C1
Marrella, A1
Immordino, P1
Vitale, F1
Amodio, E1
Wang, YD1
Yao, WL1
Xin, ZM1
Han, TT1
Wang, ZG1
Chen, L2
Cai, C1
Zhang, Y4
Ba, D1
Wen, S1
Tian, Q1
Lv, W1
Cheng, G1
Li, N1
Yue, XY1
Chu, WJ1
Chen, Q1
Choi, ES1
Zhao, X3
Zhou, HD1
Sun, XF1
Sharma, S2
Chhoker, S1
Xie, C1
Ong, EWY1
Tan, ZK1
Evans, S1
Weinheimer, CJ1
Kovacs, A1
Williams, JW1
Randolph, GJ1
Jiang, W1
Barger, PM1
Mann, DL1
Liu, J3
Huang, Y1
Kong, L1
Yu, X1
Feng, B1
Liu, D1
Zhao, B1
Mendes, GC1
Yuan, P1
Ge, D1
Wang, WM1
Fontes, EPB1
Li, P1
Shan, L1
He, P1
Katoh, T1
Sengoku, T1
Hirata, K1
Ogata, K1
Suga, H1
Shun, C1
Yong-Yi, J1
Mei-Li, C1
Shi-Li, L1
Jian-Bo, Z1
Dan-Li, W1
Zhi-Min, G1
Ibrahim, AM1
Zakhary, SY1
Amin, SAW1
Ugurlu, M1
Fornari, VJ1
Hartmann, MSM1
Vanni, JR1
Rodriguez, R1
Langaro, MC1
Pelepenko, LE1
Zaia, AA1
Nakanjako, D1
Zalwango, F1
Wairagala, P1
Luboga, F1
Andia Biraro, I1
Bukirwa, VD1
Mboowa, MG1
Cose, S1
Seeley, J1
Elliott, A1
Zhao, G1
Sun, P1
Hao, S1
Wang, X1
Qu, G1
Xing, Y1
Xu, X1
Maierhofer, M1
Rieger, V1
Mayr, T1
Liu, Y2
Zhang, Q1
Bigliardi, AP1
Fernandes, CLF1
Pinto, EA1
Dos Santos, M1
Garcia, EM1
Baisch, PRM1
Soares, MCF1
Muccillo-Baisch, AL1
da Silva Júnior, FMR1
Yu, W1
Ju, C1
Wang, K1
Zheng, Z1
Liu, H1
Gao, Y1
Martínez-Navarro, EM1
Cebrián-Tarancón, C1
Moratalla-López, N1
Lorenzo, C1
Alonso, GL1
Salinas, RM1
Bermúdez de Castro, JM1
Modesto-Mata, M1
Martín-Francés, L1
García-Campos, C1
Martínez de Pinillos, M1
Martinón-Torres, M1
Hasani, M1
Wu, F2
Warriner, K1
Kurz, M1
Gretzke, D1
Hörlein, R1
Turpault, S1
Atzrodt, J1
Derdau, V1
Yao, Y1
Ou, X1
Zhao, S1
Tian, B1
Jin, S1
Jiang, Z1
Zhou, Z1
Liu, M2
Jiang, GD1
Mou, LH1
Chen, JJ1
Li, ZY1
He, SG1
Reale, E1
Fustinoni, S1
Mercadante, R1
Polledri, E1
Hopf, NB1
Grant, PC1
Levy, K1
Lattimer, TA1
Depner, RM1
Kerr, CW1
Sato, J1
Merenda, MEZ1
Uemoto, AT1
Dos Santos, MP1
Barion, MRL1
Carciofi, AC1
de Paula Dorigam, JC1
Ribeiro, LB1
Vasconcellos, RS1
Waller, SB1
Peter, CM1
Hoffmann, JF1
Cleff, MB1
Faria de, RO1
Zani, JL1
Martins, BA1
Sande, D1
Solares, MD1
Takahashi, JA1
Yang, S2
Jia, Y1
Yin, C1
Zhao, R1
Ojha, M1
Wu, B1
Deepa, M1
Mo, J1
Au, DW1
Wan, MT1
Shi, J1
Zhang, G1
Winkler, C1
Kong, RY1
Seemann, F1
Bianco, M1
Calvano, CD1
Ventura, G1
Bianco, G1
Losito, I1
Cataldi, TRI1
Angiolella, L1
Staudt, A1
Duarte, PF1
Amaral, BPD1
Peixoto Andrade, BCO1
Simas, NK1
Correa Ramos Leal, I1
Sangenito, LS1
Santos, ALSD1
de Oliveira, D1
Junges, A1
Cansian, RL1
Paroul, N1
Siu, J1
Klingler, L1
Hung, CT1
Jeong, SH1
Smith, S1
Tingle, MD1
Wagner Mackenzie, B1
Biswas, K1
Douglas, RG1
Oza, AM1
Lorusso, D1
Aghajanian, C1
Oaknin, A1
Dean, A1
Colombo, N1
Weberpals, JI1
Clamp, AR1
Scambia, G1
Leary, A1
Holloway, RW1
Gancedo, MA1
Fong, PC1
Goh, JC1
O'Malley, DM1
Armstrong, DK1
Banerjee, S1
García-Donas, J1
Swisher, EM1
Cella, D1
Meunier, J1
Goble, S1
Cameron, T1
Maloney, L1
Mörk, AC1
Bedel, J1
Ledermann, JA1
Coleman, RL1
Vlek, SL1
Burm, R1
Govers, TM1
Vleugels, MPH1
Tuynman, JB1
Mijatovic, V1
Leicht, AS1
Connor, J1
Conduit, N1
Vaquera, A1
Gómez, MA1
McKay, JA1
Church, AL1
Rubin, N1
Emory, TH1
Hoven, NF1
Kuehn-Hajder, JE1
Nelson, MT1
Ramanna, S1
Auerbach, EJ1
Moeller, S1
Bolan, PJ1
Fox, NP1
Leonard, M1
Sjerps, MJ1
Chang, EF1
Hyun, S1
Saejio, A1
Shanmugam, S1
Liu, X1
Sun, M1
Bai, Z1
Jaque-Fernandez, F1
Beaulant, A1
Berthier, C1
Monteiro, L1
Allard, B1
Casas, M1
Rieusset, J1
Jacquemond, V1
Góngora-García, OR1
Aca-Aca, G1
Baz-Rodríguez, SA1
Monte, A1
Maganaris, C1
Baltzopoulos, V1
Zamparo, P1
Wang, Z2
Hou, Y1
Cai, L1
Tu, YJ1
Tan, B1
Jiang, L1
Wu, ZH1
Yu, HJ1
Li, XQ1
Yang, AD1
Titze, IR1
Palaparthi, A1
Mau, T1
González, MA1
Goiri, F1
Barandika, JF1
García-Pérez, AL1
Jatt, LP1
Gandhi, MM1
Guo, R1
Sukhija-Cohen, A1
Bhattacharya, D1
Tseng, CH1
Chew, KW1
Onwumere, J1
Pia Tek, J1
Budnyak, T1
Budnyk, S1
Karim, Z1
Thersleff, T1
Kuśtrowski, P1
Mathew, AP1
Slabon, A1
Guo, M1
Zhao, T1
Xing, Z1
Qiu, Y1
Pan, K1
Li, Z2
Zhou, W1
Ghassemi Tabrizi, S1
Arbuznikov, AV1
Jiménez-Hoyos, CA1
Kaupp, M1
Lin, MH2
Bulman, DM1
Remucal, CK1
Chaplin, BP1
Laguerre, A1
George, LA1
Gall, ET1
Emerson, MS1
Wang, H3
Maginn, EJ1
Margulis, CJ1
Li, H2
Feng, W1
Kang, X2
Yan, S1
Chao, M1
Mo, S1
Sun, W1
Lu, Y1
Chen, C1
Stevens, DM1
Adiseshaiah, P1
Dasa, SSK1
Potter, TM1
Skoczen, SL1
Snapp, KS1
Cedrone, E1
Patel, N1
Busman-Sahay, K1
Rosen, EP1
Sykes, C1
Cottrell, M1
Dobrovolskaia, MA1
Estes, JD1
Kashuba, ADM1
Stern, ST1
Özütemiz, C1
Neil, EC1
Tanwar, M1
Rubin, NT1
Ozturk, K1
Cayci, Z1
Duscha, BD1
Kraus, WE1
Jones, WS1
Robbins, JL1
Piner, LW1
Huffman, KM1
Allen, JD1
Annex, BH1
Mehmood, T1
Ahmad, I1
Bibi, S1
Mustafa, B1
Ali, I1
Dahal, RH1
Chaudhary, DK1
Kim, DU1
Kim, J1
Yeter, HH1
Gonul, I1
Guz, G1
Helvaci, O1
Korucu, B1
Akcay, OF1
Derici, U1
Arinsoy, T1
Neffati, R1
Judeinstein, P1
Rault, J1
Xu, Y1
Chai, X1
Ren, T1
Yu, S1
Fu, Q2
Ye, J1
Ge, X1
Song, J1
Yang, H2
El-Baba, TJ1
Lutomski, CA1
Kantsadi, AL1
Malla, TR1
John, T1
Mikhailov, V1
Bolla, JR1
Schofield, CJ1
Zitzmann, N1
Vakonakis, I1
Robinson, CV1
Langham, MC1
Caporale, AS1
Wehrli, FW1
Parry, S1
Schwartz, N1
den Boer, RB1
Jones, KI1
Ash, S1
van Boxel, GI1
Gillies, RS1
O'Donnell, T1
Ruurda, JP1
Sgromo, B1
Silva, MA1
Maynard, ND1
Sivieri, EM1
Eichenwald, EC1
Rub, D1
Abbasi, S1
Krahnert, I1
Bolze, A1
Gibon, Y1
Fernie, AR1
Huang, L1
Wan, Y1
Dang, Z1
Yang, P1
Yang, Q1
Wu, S2
Lin, CC1
Hsu, CT1
Liu, W2
Huang, SC1
Kortz, U1
Mougharbel, AS1
Chen, TY1
Hu, CW1
Lee, JF1
Wang, CC1
Liao, YF1
Li, LJ1
Li, L1
Peng, S1
Stimming, U1
Hebbar Kannur, K1
Yaqub, TB1
Pupier, C1
Héau, C1
Cavaleiro, A1
Yamamoto, S1
Ono, A1
Matsui, J1
Hoshino, N1
Akutagawa, T1
Miyashita, T1
Mitsuishi, M1
Patel, SM1
Smith, TG1
Morton, M1
Stiers, KM1
Seravalli, J1
Mayclin, SJ1
Edwards, TE1
Tanner, JJ1
Becker, DF1
Butcher, TW1
Yang, JL1
Hartwig, JF1
Yu, MF1
Xia, ZZ1
Yao, JC1
Feng, Z1
Li, DH1
Liu, T1
Cheng, GJ1
He, DL1
Li, XH1
Huurman, R1
Schinkel, AFL1
de Jong, PL1
van Slegtenhorst, MA1
Hirsch, A1
Michels, M1
Kataja, A1
Tarvasmäki, T1
Lassus, J1
Sionis, A1
Mebazaa, A1
Pulkki, K1
Banaszewski, M1
Carubelli, V1
Hongisto, M1
Jankowska, E1
Jurkko, R1
Jäntti, T1
Kasztura, M1
Parissis, J1
Sabell, T1
Silva-Cardoso, J1
Spinar, J1
Tolppanen, H1
Harjola, VP1
Carsetti, A1
Damiani, E1
Casarotta, E1
Scorcella, C1
Domizi, R1
Gasparri, F1
Gabbanelli, V1
Pantanetti, S1
Carozza, R1
Adrario, E1
Donati, A1
Almada, E1
Pariani, A1
Rivabella Maknis, T1
Hidalgo, F1
Vena, R1
Favre, C1
Larocca, MC1
Lu, ZY1
Jiang, WD1
Wu, P1
Kuang, SY1
Tang, L1
Yang, J1
Zhou, XQ1
Feng, L1
Leal, M1
Zampini, IC1
Mercado, MI1
Moreno, MA1
Simirgiotis, MJ1
Bórquez, J1
Ponessa, G1
Isla, MI1
Saliu, IO1
Amoo, ZA1
Khan, MF1
Olaleye, MT1
Rema, V1
Akinmoladun, AC1
Khan, AU1
Rahman, AU1
Yuan, Q1
Ahmad, A1
Khan, ZUH1
Mahnashi, MH1
Alyami, BA1
Alqahtani, YS1
Ullah, S1
Wirman, AP1
Gao, M1
Deng, L1
Zhang, K1
Wang, M1
Xia, Z1
Gao, D1
Balkissou, AD1
Poka-Mayap, V1
Massongo, M1
Djenabou, A1
Endale-Mangamba, LM1
Olomo, EJ1
Boulleys-Nana, JR1
Diffo-Sonkoue, L1
Adidigue-Ndiome, R1
Alexandra, AJE1
Haman-Wabi, AB1
Adama, S1
Iddi-Faical, A1
Pefura-Yone, EW1
Zhao, Q1
Tong, W1
Ge, C1
Zhao, D1
Norbäck, D1
Li, B1
Zhao, Z1
Huang, C1
Zhang, X2
Qian, H1
Yang, X1
Sun, Y1
Sundell, J1
Deng, Q1
Kim, HJ1
Jeon, JW1
Hwang, SM1
Chu, KI1
Cha, YH1
Kwak, YD1
Choi, SD1
Aslam, M1
Kim, CG1
Zhou, J1
Yang, E1
Yang, W1
Zhao, M1
Yao, J1
Meng, X1
Cui, Y1
Zhu, T1
Sun, F2
Teng, L2
Derry, S1
Wiffen, PJ1
Kalso, EA1
Bell, RF1
Aldington, D1
Phillips, T1
Gaskell, H1
Moore, RA1
Chen, Z1
Xing, L1
Fan, Q1
Cheetham, AG1
Lin, R1
Holt, B1
Xiao, Y1
Cui, H1
Yu, C1
Sun, X1
Long, C1
Lee, RJ1
Liu, N1
Choi, JK1
Kim, SW1
Kim, DS1
Lee, JY1
Lee, S1
Oh, HM1
Ha, YS1
Yoo, J1
Park, PH1
Shin, TY1
Kwon, TK1
Rho, MC1
Kim, SH1
Nagai, N1
Iwamae, A1
Tanimoto, S1
Yoshioka, C1
Ito, Y1
Nozaki, S1
Ozaki, N1
Suzuki, S1
Goto, M1
Mawatari, A1
Nakatani, Y1
Hayashinaka, E1
Wada, Y1
Doi, H1
Watanabe, Y1
Shinkai, N1
Korenaga, K1
Mizu, H1
Yamauchi, H1
Kawai, S1
Uchida, E1
Kondo, M1
Ohno, S1
Obata, J1
Nawata, Y1
Sugimoto, K2
Oribe, M1
Nagaya, I1
Lotlikar, V1
Kedar, U1
Shidhaye, S1
Kadam, V1
Główka, F1
Karaźniewicz-Łada, M1
Grześkowiak, E1
Rogozinska, D1
Romanowski, W1
Balabanova, RM1
Kennedy, AC3
Köhler, G2
Mohing, W1
Lutz, D1
Morand, J1
Camus, JP1
Fournie, A3
Ayrolles, C3
Koeger, AC1
Prier, A1
Harrewyn, JM2
Amor, B2
Acqaviva, B1
Cayla, J1
Delcambre, B1
Le Goff, P2
Loyau, G1
Serratrice, G1
Ziegler, G1
Huck, F1
Lecocq, J1
Meyer, R1
Kuntz, JL1
Asch, L1
Ibba, G1
Uras, R1
Perpignano, G1
Ward, JR1
Isomäki, H1
Martio, J1
Kaarela, K1
Kajander, A1
Koota, K1
Lehtinen, K1
Luukkainen, R1
Martio, T1
Nissilä, M1
Nuotio, P1
Zimmermann-Górska, I1
Koperska, M1
Senger-Kuczyńska, M1
Wojtulewski, JA1
Gow, PJ2
Walter, J1
Grahame, R5
Gibson, T2
Panayi, GS2
Mason, J1
Shichikawa, K1
Nobunaga, T1
Iwasaki, T1
Jonderko, G1
Gabryel, A1
Gałaszek, Z1
Dyczek-Parys, E1
Nowicki, L1
Szczesny-Siwinski, H1
Wollheim, FA2
Stenberg, P1
Nilsson, B1
Mellbin, G1
Tracy, TS1
Worster, T1
Bradley, JD1
Greene, PK1
Brater, DC1
Uddenfeldt, P1
Leden, I1
Rubin, B1
Skeith, KJ1
Russell, AS1
Jamali, F1
Sallì, L1
Martín-Mola, E1
Gijón-Baños, J1
Ansoleaga, JJ1
Rass, H1
Hayball, PJ1
Nation, RL1
Bochner, F1
Sansom, LN1
Ahern, MJ2
Tugwell, P1
Ludwin, D1
Gent, M1
Roberts, R1
Bensen, W1
Grace, E1
Baker, P1
Walker, JS1
Sheather-Reid, RB1
Carmody, JJ1
Vial, JH1
Day, RO1
Tobetto, K1
Yamamoto, Y1
Kataoka, M1
Ando, T1
Himeno, M1
Savarino, V1
Mela, GS1
Zentilin, P1
Cimmino, MA1
Parisi, M1
Mele, MR1
Pivari, M1
Bisso, G1
Celle, G1
Jokhio, IA1
Siddiqui, KA1
Waraich, T1
Abbas, M1
Ali, A1
Lee, P1
Anderson, JA1
Miller, J1
Webb, J1
Buchanan, WW2
Huskisson, EC2
Accardo, S1
Traverso, A1
Caraffa, M1
Ferretti, A1
Moreno, M1
Sala, G2
Silvestri, N1
Castegnaro, E1
Pollini, C3
Calin, A1
Bennett, RM1
Sukhupunyaraksa, S1
Goldman, AL1
Montoya, HE1
O'Brien, WM2
Giuliano, VJ1
Schmid, FR1
Willkens, RF1
Sakofsky, HY1
Reinicke, C1
Ricciardi, S1
Filosa, E1
Giaccai, L1
Melani, F1
Pengue, L1
Usobiaga Marchal, JL1
Howard, DL1
Lindroth, Y1
Sjöblom, KG1
Griffin, AJ1
Bloch, M1
Pemberton, RE1
Strand, LJ1
Mathies, H1
Meyer, W1
Montrone, F1
Fumagalli, M1
Pellegrini, P1
Ratti, G1
Liverta, C2
Pontiroli, AE2
Pavelka, K1
Vojtísek, O1
Bremová, A1
Gross, W1
Kaller, H1
Corrigall, V1
Woolf, DL1
Balme, HW1
Scott, J1
Franklin, S1
Fostiropoulos, G1
Franchi, R1
Viara, M1
Grunwaldt, E1
Peltola, P3
Sydnes, O1
Brath, HK2
Haerum, LB2
Straume, S2
Burry, HC1
Zutshi, D1
Mason, M1
Fossgreen, J2
Kirchheiner, B2
Petersen, FO1
Tophoj, E2
Zachariae, E2
Lussier, A1
Camerlain, M1
Menard, H1
Myhal, D1
Wehner, S2
Winkler, E1
El-Ghobarey, AF1
Rennie, JA1
Hadidi, T1
Hamid, HA1
Mavrikakis, M1
Sydnes, OA1
David-Chaussé, J1
Dehais, J1
Bullier, R1
Queneau, P1
Amourdedieu, J1
Daumont, A1
Simon, L1
Blotman, F1
Sany, J1
Serre, H1
Gomez, G1
Digby, JW1
Jabeen, S1
Akram, G1
Hassan, NW1
Klein, G2
Wottawa, A2
Mason, DI1
Brooks, PM1
Binns, TB1
Toussaint, F1
de Buisseret, JP1
Isaac, G1
Remans, J1
Wetherall, M1
Leslie, A1
James, RH1
Roberts-Thomson, PJ1
Rennie, GC1
Pincus, T1
Marcum, SB1
Callahan, LF1
Adams, RF1
Barber, J1
Barth, WF1
Gordon, GV1
Huston, JW1
Polk, JR1
Whelton, JC1
Dougados, M1
Listrat, V1
Duchesne, L1
Arone, S1
Warabi, H1
Ogawa, N1
Azuma, T1
Fine, IT1
Perepel'chenko, AI1
Borisiuk, BE1
Bulakh, EP1
Levin, IV1
Ternovoĭ, NK1
Caldwell, JR1
Germain, BF1
Lourie, SH1
McLaughlin, GE1
Poiley, JE1
Vreede, PD1
Wilson, CH1
Boey, ML1
Rae, S1
Feng, PH1
Chivabongs, A1
De Bono, GG1
Pearlgood, M1
Valentini, G1
Tirri, G1
Longatti, S1
McCrea, JD1
Telford, AM1
Kaye, CM1
Boyd, MW1
Youinou, P1
Lepoivre, B1
Jouquan, J1
Christophidis, N1
Rotstein, A1
Louis, WJ1
Pullar, T1
Zoma, AA1
Madhok, R1
Hunter, JA1
Capell, HA1

Reviews

6 reviews available for ketoprofen and Rheumatoid Arthritis

ArticleYear
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews.
    The Cochrane database of systematic reviews, 2017, 05-12, Volume: 5

    Topics: Acute Pain; Adult; Analgesics; Arthritis, Rheumatoid; Capsaicin; Chronic Pain; Diclofenac; Humans; K

2017
[Current concepts of pharmacotherapy in rheumatoid arthritis].
    Vestnik Rossiiskoi akademii meditsinskikh nauk, 2003, Issue:7

    Topics: Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents

2003
Update on ibuprofen for rheumatoid arthritis.
    The American journal of medicine, 1984, Jul-13, Volume: 77, Issue:1A

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Drug Tolerance;

1984
Antiinflammatory drugs.
    Seminars in arthritis and rheumatism, 1977, Volume: 7, Issue:1

    Topics: Adult; Anti-Inflammatory Agents; Apazone; Arthritis, Rheumatoid; Aspirin; Benzylidene Compounds; Chi

1977
[Nonsteroid antirheumatic agents].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977, Jul-15, Volume: 32, Issue:14

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Fenoprofen; Flufenamic Acid; Humans; Indomethacin;

1977

Trials

72 trials available for ketoprofen and Rheumatoid Arthritis

ArticleYear
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Efficacy and safety of ketoprofen patch in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
    Journal of clinical pharmacology, 2010, Volume: 50, Issue:10

    Topics: Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Double-Bl

2010
[Double-blind comparative study of Bi-Profenid tablets and Profenid capsules in inflammatory rheumatism].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1983, Dec-12, Volume: 59, Issue:46

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Capsules; Child; Clinical Trials as Topic; Delayed-A

1983
[Double-blind comparative study of slow-release ketoprofen and a placebo in chronic inflammatory rheumatism].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1983, Dec-12, Volume: 59, Issue:46

    Topics: Adult; Aged; Arthritis; Arthritis, Rheumatoid; Chronic Disease; Clinical Trials as Topic; Delayed-Ac

1983
[Open clinical trial of a new oral galenic form of ketoprofen].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1983, Dec-12, Volume: 59, Issue:46

    Topics: Administration, Oral; Adult; Aged; Arthritis, Rheumatoid; Capsules; Clinical Trials as Topic; Delaye

1983
Double-blind comparison of glucametacin and ketoprofen in chronic arthropathies.
    Current medical research and opinion, 1983, Volume: 8, Issue:5

    Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind

1983
Update on ibuprofen for rheumatoid arthritis.
    The American journal of medicine, 1984, Jul-13, Volume: 77, Issue:1A

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Drug Tolerance;

1984
Comparison of the analgesic effect of ten nonsteroidal anti-inflammatory drugs.
    British journal of rheumatology, 1984, Volume: 23, Issue:1

    Topics: Adult; Aged; Analgesics; Anti-Inflammatory Agents; Apazone; Arthritis, Rheumatoid; Aspirin; Carbazol

1984
[Pirprofen in the treatment of rheumatoid arthritis].
    La Nouvelle presse medicale, 1982, Aug-28, Volume: 11, Issue:33

    Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind

1982
[Clinical evaluation of profenid].
    Reumatologia, 1980, Volume: 18, Issue:3

    Topics: Adult; Aged; Arthritis, Rheumatoid; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Female;

1980
Clotrimazole in rheumatoid arthritis.
    Annals of the rheumatic diseases, 1980, Volume: 39, Issue:5

    Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Humans; Imidazol

1980
[A controlled double-blind clinical trial of ketoprofen suppository in rheumatoid arthritis (author's transl)].
    Ryumachi. [Rheumatism], 1982, Volume: 22, Issue:2

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Femal

1982
[Comparative crossover double-blind study of profenid and indomethacin patients with rheumatoid arthritis].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1982, Apr-15, Volume: 37, Issue:8

    Topics: Adult; Aged; Arthritis, Rheumatoid; Double-Blind Method; Female; Humans; Indomethacin; Ketoprofen; M

1982
Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis.
    British journal of clinical pharmacology, 1994, Volume: 37, Issue:5

    Topics: Administration, Oral; Adult; Aged; Arthritis, Rheumatoid; Drug Interactions; Drug Therapy, Combinati

1994
A double-blind comparison of oral ketoprofen 'controlled release' and indomethacin suppository in the treatment of rheumatoid arthritis with special regard to morning stiffness and pain on awakening.
    Current medical research and opinion, 1993, Volume: 13, Issue:3

    Topics: Administration, Rectal; Adult; Aged; Ambulatory Care; Arthritis, Rheumatoid; Central Nervous System

1993
Ketoprofen pharmacokinetics in the elderly: influence of rheumatic disease, renal function, and dose.
    Journal of clinical pharmacology, 1993, Volume: 33, Issue:11

    Topics: Age Factors; Aged; Aged, 80 and over; Aging; Arthritis, Rheumatoid; Female; Humans; Ketoprofen; Kidn

1993
[Efficacy and tolerability of ketoprofene administered through iontophoresis in rheumatoid arthritis. Results from a multicentric study].
    La Clinica terapeutica, 1993, Volume: 142, Issue:6

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Evaluation; Fema

1993
Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis.
    Rheumatology international, 1995, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac;

1995
The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis.
    British journal of clinical pharmacology, 1993, Volume: 36, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, R

1993
Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs.
    The Journal of rheumatology, 1997, Volume: 24, Issue:6

    Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antir

1997
Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders".
    Arthritis and rheumatism, 1997, Volume: 40, Issue:11

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Blood Sedimentation; Cr

1997
Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis.
    The Journal of rheumatology, 1976, Volume: 3, Issue:3

    Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Clinical Tri

1976
Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis.
    The Journal of rheumatology, 1977,Summer, Volume: 4, Issue:2

    Topics: Adult; Aged; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Drug Evaluation; Female

1977
[Ketoprofen in rheumatic arthropathies in old age. Double-blind studies].
    La Clinica terapeutica, 1977, Dec-31, Volume: 83, Issue:6

    Topics: Aged; Arthritis; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Drug Evaluati

1977
[Results of a double-blind controlled study of the comparative effects of ketoprofen and ibuprofen in orthopedic patients].
    La Clinica terapeutica, 1978, Feb-28, Volume: 84, Issue:4

    Topics: Adult; Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation;

1978
[Ketoprofen in the treatment of rheumatisms].
    Revista espanola de reumatismo y enfermedades osteoarticulares, 1978, Volume: 21, Issue:1

    Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Injections, Intram

1978
A double-blind crossover evaluation of ketoprofen (Orudis) and placebo in rheumatoid arthritis with assessment of long-term tolerance.
    The Journal of international medical research, 1978, Volume: 6, Issue:4

    Topics: Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Ketoprof

1978
Panel discussion on clinical trials: comparison of different trials.
    Rheumatology and rehabilitation, 1978, Volume: Suppl

    Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Evaluation; Humans; Indomethacin; Ketoprofen;

1978
A comparison of ketoprofen and naproxen in rheumatoid arthritis.
    Rheumatology and rehabilitation, 1978, Volume: Suppl

    Topics: Adult; Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; J

1978
Ketoprofen: double-blind cross-over study with indomethacin administered as a combined suppository/capsule regime in patients with rheumatoid arthritis. A preliminary report.
    Rheumatology and rehabilitation, 1978, Volume: Suppl

    Topics: Administration, Oral; Adult; Aged; Arthritis, Rheumatoid; Capsules; Clinical Trials as Topic; Double

1978
A review of upper-gastrointestinal effects of the newer nonsteroidal antiinflammatory agents.
    Digestive diseases and sciences, 1979, Volume: 24, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Clinical Trials as

1979
Clinical studies with ketoprofen in rheumatoid arthritis.
    Rheumatology and rehabilitation, 1979, Volume: Suppl

    Topics: Administration, Oral; Arthritis, Rheumatoid; Clinical Trials as Topic; Humans; Ketoprofen; Phenylpro

1979
Combined oral and rectal administration of ketoprofen.
    Rheumatology and rehabilitation, 1979, Volume: Suppl

    Topics: Administration, Oral; Arthritis, Rheumatoid; Clinical Trials as Topic; Humans; Ketoprofen; Phenylpro

1979
A double-blind cross-over evaluation of ketoprofen (Orudis) and ibuprofen in the management of rheumatoid arthritis.
    Rheumatology and rehabilitation, 1979, Volume: 18, Issue:2

    Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Ibuprofen; Ket

1979
[Differences in the effectiveness of ketoprofen administered per os and per rectum].
    Fysiatricky a reumatologicky vestnik, 1979, Volume: 57, Issue:4

    Topics: Administration, Oral; Arthritis, Rheumatoid; Clinical Trials as Topic; Female; Humans; Ketoprofen; M

1979
Four new anti-inflammatory drugs: responses and variations.
    British medical journal, 1976, May-01, Volume: 1, Issue:6017

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Fenoprofen; Gastrointesti

1976
A double-blind cross-over study of clopirac and ketoprofen in rheumatoid arthritis.
    Journal belge de rhumatologie et de medecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde, 1975, Volume: 30 Spec no

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Humans; Ke

1975
Ketoprofen and indomethacin in the treatment of rheumatoid arthritis: a double-blind cross-over trial.
    European journal of clinical pharmacology, 1975, Apr-04, Volume: 8, Issue:3-4

    Topics: Adult; Aged; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Drug Administration Sch

1975
Ketoprofen in the treatment of rheumatoid arthritis. Double-blind, cross-over placebo comparison.
    Scandinavian journal of rheumatology. Supplement, 1976, Volume: 1976, Issue:0

    Topics: Analgesics; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Drug Evaluation; Gastroi

1976
A double-blind cross-over study of ketoprofen and phenylbutazone in rheumatoid arthritis.
    Scandinavian journal of rheumatology. Supplement, 1976, Volume: 1976, Issue:0

    Topics: Analgesics; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Drug Evaluation; Gastroi

1976
Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis. Results of a multi-centre, double-blind, cross-over trial against phenylbutazone.
    Scandinavian journal of rheumatology. Supplement, 1976, Volume: 1976, Issue:0

    Topics: Adult; Aged; Analgesics; Arthritis, Rheumatoid; Benzophenones; Capsules; Clinical Trials as Topic; D

1976
Ketoprofen -- a new anti-rheumatic agent.
    Scandinavian journal of rheumatology. Supplement, 1976, Volume: 1976, Issue:0

    Topics: Analgesics; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Drug Evaluation; Gastroi

1976
Ketoprofen in rheumatoid arthritis: its tolerance and therapeutic effect.
    Scandinavian journal of rheumatology. Supplement, 1976, Volume: 1976, Issue:0

    Topics: Adult; Aged; Analgesics; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Drug Evalua

1976
Clinical evaluation of ketoprofen (19.583 R.P.) in rheumatoid arthritis. Double-blind cross-over comparison with indomethacin.
    Scandinavian journal of rheumatology. Supplement, 1976, Volume: 1976, Issue:0

    Topics: Adult; Aged; Analgesics; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Drug Evalua

1976
A double-blind cross-over evaluation of ketoprofen and aspirin in rheumatoid arthritis.
    Scandinavian journal of rheumatology. Supplement, 1976, Volume: 1976, Issue:0

    Topics: Adult; Aged; Analgesics; Arthritis, Rheumatoid; Aspirin; Benzophenones; Clinical Trials as Topic; Dr

1976
[Alrheumum in the daily practice].
    Fortschritte der Medizin, 1976, Nov-11, Volume: 94, Issue:32

    Topics: Administration, Oral; Adolescent; Adult; Arthritis, Rheumatoid; Benzophenones; Blood Glucose; Bursit

1976
A comparative trial of large doses of ketoprofen and indomethacin in the treatment of rheumatoid arthritis.
    Current medical research and opinion, 1976, Volume: 4, Issue:6

    Topics: Adolescent; Adult; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Female; Humans; I

1976
Ketoprofen - clinical efficacy.
    Rheumatology and rehabilitation, 1976, Volume: Suppl

    Topics: Acetaminophen; Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoid; Aspirin; Benzophenones; C

1976
Ketoprofen in the treatment of rheumatoid arthritis.
    Rheumatology and rehabilitation, 1976, Volume: Suppl

    Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Benzophenones; Clinical Trial

1976
Clinical evaluation of keto profen (Orudis) in rheumatoid arthritis: results of a multi-centre double-blind trial against phenylbutazone.
    Rheumatology and rehabilitation, 1976, Volume: Suppl

    Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topi

1976
Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis: a double-blind cross-over comparison with indomethacin.
    Rheumatology and rehabilitation, 1976, Volume: Suppl

    Topics: Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Hum

1976
Double-blind cross-over study of ketoprofen and phenylbutazone in rheumatoid arthritis.
    Rheumatology and rehabilitation, 1976, Volume: Suppl

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Humans; Ke

1976
Results of the rectal administration of ketoprofen in fifty-two patients.
    Rheumatology and rehabilitation, 1976, Volume: Suppl

    Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoid; Benzophenones; Clinical Tri

1976
A clinical study of ketoprofen suppositories.
    Rheumatology and rehabilitation, 1976, Volume: Suppl

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Humans; Ke

1976
Clinical study of ketoprofen administered rectally in rheumatology.
    Rheumatology and rehabilitation, 1976, Volume: Suppl

    Topics: Adult; Aged; Analgesia; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Benzophenones; Clinical Tri

1976
Ketoprofen suppositories in rheumatological practice.
    Rheumatology and rehabilitation, 1976, Volume: Suppl

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Benzophenones; Clinical Tr

1976
A study of ketoprofen in rheumatoid arthritis.
    Rheumatology and rehabilitation, 1976, Volume: Suppl

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Benz

1976
Long-term safety study of ketoprofen.
    Rheumatology and rehabilitation, 1976, Volume: Suppl

    Topics: Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Hum

1976
A double-blind crossover comparison of Orudis (ketoprofen) and indomethacin in the treatment of rheumatoid arthritis.
    The Journal of international medical research, 1976, Volume: 4, Issue:6

    Topics: Arthritis, Rheumatoid; Benzophenones; Clinical Trials as Topic; Double-Blind Method; Female; Humans;

1976
Long-term treatment with ketoprofen in rheumatoid arthritis. A clinical trial with special reference to side-effects.
    Scandinavian journal of rheumatology. Supplement, 1976, Volume: 1976, Issue:0

    Topics: Analgesics; Arthritis, Rheumatoid; Aspirin; Benzophenones; Clinical Trials as Topic; Diarrhea; Drug

1976
A comparison of ketoprofen SR and sulindac in the elderly with rheumatoid arthritis.
    The British journal of clinical practice, 1992,Winter, Volume: 46, Issue:4

    Topics: Aged; Arthritis, Rheumatoid; Double-Blind Method; Female; Humans; Ketoprofen; Male; Sulindac; Treatm

1992
[Comparative efficacy of ketoprofen related to the route of administration (intramuscular or per os). A double-blind study versus placebo in rheumatoid arthritis].
    Revue du rhumatisme et des maladies osteo-articulaires, 1992, Nov-30, Volume: 59, Issue:11

    Topics: Administration, Oral; Adult; Aged; Arthritis, Rheumatoid; Double-Blind Method; Humans; Injections, I

1992
[Clinical evaluation of pain. Value of a 2-dimensional index of pain].
    Revue du rhumatisme et des maladies osteo-articulaires, 1989, Volume: 56, Issue:1

    Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Humans; Ketoprofen; Pain; Phenylpropionates

1989
[Assessment of efficacy of RPY-001 in rheumatoid arthritis].
    Ryumachi. [Rheumatism], 1989, Volume: 29, Issue:4

    Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; C

1989
[Use of flugalin and profenid in patients with rheumatoid arthritis].
    Vrachebnoe delo, 1988, Issue:6

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Clinical Trials as Topi

1988
Ketoprofen versus indomethacin in patients with rheumatoid arthritis: a multicenter double blind comparative study.
    The Journal of rheumatology, 1988, Volume: 15, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Double-Blind Method; Female; Humans; Indometh

1988
Comparison of efficacy of and tolerance to ketoprofen and diclofenac sodium in the treatment of rheumatoid arthritis.
    Singapore medical journal, 1988, Volume: 29, Issue:3

    Topics: Adult; Aged; Arthritis, Rheumatoid; Delayed-Action Preparations; Diclofenac; Female; Humans; Ketopro

1988
General practice trials: a reappraisal in the light of the findings of a general practice study of Oruvail.
    The British journal of clinical practice, 1986, Volume: 40, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Clinical Trials as Topic; Family

1986
Relative efficacy and tolerance of tiaprofenic acid and ketoprofen in rheumatoid arthritis.
    Drugs, 1988, Volume: 35 Suppl 1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Tolerance; Female; Human

1988
A comparison of plasma and synovial fluid profiles of standard and controlled-release formulations of ketoprofen in patients with rheumatoid arthritis.
    Current medical research and opinion, 1986, Volume: 10, Issue:2

    Topics: Aged; Arthritis, Rheumatoid; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Met

1986
Have the newer NSAIDS contributed to the management of rheumatoid arthritis?
    Scottish medical journal, 1985, Volume: 30, Issue:3

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Blood Sedimentation; Feprazone; Flurbiprofen; Human

1985
Naproxen (Naprosyn) and ketoprofen (Orudis).
    Drug and therapeutics bulletin, 1974, Mar-29, Volume: 12, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Benzophenones; Clinical Trials as

1974

Other Studies

41 other studies available for ketoprofen and Rheumatoid Arthritis

ArticleYear
6,11-Dihydro-11-oxodibenz [b,e] oxepinacetic acids with potent antiinflammatory activity.
    Journal of medicinal chemistry, 1976, Volume: 19, Issue:7

    Topics: Acetates; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Dibenzoxepins; Edema; Female; Le

1976
Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Management of Rheumatoid Arthritis.
    Journal of medicinal chemistry, 2018, 06-14, Volume: 61, Issue:11

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Carbonic Anhydrase Inhibito

2018
Bioisosteric Development of Multitarget Nonsteroidal Anti-Inflammatory Drug-Carbonic Anhydrases Inhibitor Hybrids for the Management of Rheumatoid Arthritis.
    Journal of medicinal chemistry, 2020, 03-12, Volume: 63, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Carbonic Anhydrase Inhibito

2020
Polyketal Nanoparticles Co-Loaded With miR-124 and Ketoprofen for Treatment of Rheumatoid Arthritis.
    Journal of pharmaceutical sciences, 2021, Volume: 110, Issue:5

    Topics: Animals; Arthritis, Rheumatoid; Drug Carriers; Ketoprofen; MicroRNAs; Nanoparticles; Particle Size;

2021
Drug-Bearing Supramolecular Filament Hydrogels as Anti-Inflammatory Agents.
    Theranostics, 2017, Volume: 7, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cells, Cultured; Drug Carriers; Fibroblast

2017
Ketoprofen and MicroRNA-124 Co-loaded poly (lactic-co-glycolic acid) microspheres inhibit progression of Adjuvant-induced arthritis in rats.
    International journal of pharmaceutics, 2018, Dec-01, Volume: 552, Issue:1-2

    Topics: Animals; Ankle Joint; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Arthritis, R

2018
Oleanolic acid acetate inhibits rheumatoid arthritis by modulating T cell immune responses and matrix-degrading enzymes.
    Toxicology and applied pharmacology, 2016, Jan-01, Volume: 290

    Topics: Adult; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Bone and Bones; Cartilage; Cell Surv

2016
Pharmacokinetics and Antiinflammatory Effect of a Novel Gel System Containing Ketoprofen Solid Nanoparticles.
    Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:12

    Topics: Acrylates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Arthritis, Rhe

2015
Development of Diagnostic Techniques for Early Rheumatoid Arthritis Using Positron Emission Tomography with [
    Molecular imaging and biology, 2017, Volume: 19, Issue:5

    Topics: Animals; Arthritis, Rheumatoid; Carbon Radioisotopes; Disease Models, Animal; Female; Imaging, Three

2017
Intra-articular penetration of ketoprofen and analgesic effects after topical patch application in rats.
    Journal of controlled release : official journal of the Controlled Release Society, 2008, Oct-21, Volume: 131, Issue:2

    Topics: Administration, Cutaneous; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; A

2008
pH-responsive dual pulse multiparticulate dosage form for treatment of rheumatoid arthritis.
    Drug development and industrial pharmacy, 2010, Volume: 36, Issue:11

    Topics: Acrylic Resins; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Delayed-Action Prepa

2010
Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis.
    European journal of drug metabolism and pharmacokinetics, 2011, Volume: 36, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aryl Hydrocarbon Hydrox

2011
[Pharmacokinetics of ketoprofen in the synovial fluid].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1983, Dec-12, Volume: 59, Issue:46

    Topics: Administration, Oral; Arthritis, Rheumatoid; Female; Humans; Ketoprofen; Kinetics; Male; Phenylpropi

1983
[Drug concentrations in blood, synovial fluid, synovial membrane, periarticular bone, muscle and adipose tissue in patients with rheumatoid polyarthritis receiving a single intramuscular injection of ketoprofen or acetylsalicylic acid (3 hours after the i
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1983, Dec-12, Volume: 59, Issue:46

    Topics: Adipose Tissue; Arthritis, Rheumatoid; Aspirin; Bone and Bones; Chromatography, Gas; Female; Humans;

1983
[Clinical study of Bi-Profenid in rheumatologic practice].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1983, Dec-12, Volume: 59, Issue:46

    Topics: Adult; Aged; Arthritis, Rheumatoid; Delayed-Action Preparations; Female; Humans; Ketoprofen; Male; M

1983
[Distribution of non-steroidal anti-inflammatory agents in human tissues].
    Fortschritte der Medizin, 1982, Oct-07, Volume: 100, Issue:37

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Humans; Indoleacetic Acids; Indomethacin; Ketoprofe

1982
Clinical and methodological studies on intramuscular ketoprofen in postoperative rheumatic pain.
    European journal of clinical pharmacology, 1981, Volume: 20, Issue:6

    Topics: Adult; Aged; Arthritis, Rheumatoid; Drug Evaluation; Female; Humans; Injections, Intramuscular; Keto

1981
[Ketoprofen--a first-class nonsteroidal antirheumatic agent].
    Deutsche medizinische Wochenschrift (1946), 1997, Feb-28, Volume: 122, Issue:9 Suppl

    Topics: Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dose-Response Rela

1997
The effects of a newly developed nonsteroidal anti-inflammatory drug (M-5011) on arachidonic acid metabolism in rheumatoid synovial fibroblasts.
    Japanese journal of pharmacology, 1997, Volume: 75, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arthritis, Rheumatoid; Bradykinin; Carbon

1997
Effect of one-month treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:3

    Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Case-Control S

1998
Study of efficacy and tolerance of ketoprofen and diclofenac sodium in the treatment of acute rheumatic and traumatic conditions.
    JPMA. The Journal of the Pakistan Medical Association, 1998, Volume: 48, Issue:12

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Diclofenac; Female; Humans; Ketoprofen; Male; Middle

1998
Trends in the drug treatment of rheumatic diseases. Proceedings of an Anglo-Nordic symposium, Guy's Hospital, London, February 1978.
    Rheumatology and rehabilitation, 1978, Volume: Suppl

    Topics: Arthritis, Rheumatoid; Congresses as Topic; England; Humans; Ketoprofen; Rheumatic Diseases; Scandin

1978
[Use of a new non-steroid, anti-inflammatory drug, ketoprofen, in the therapy of rheumatic diseases].
    Minerva medica, 1978, Oct-27, Volume: 69, Issue:51

    Topics: Adult; Aged; Arthritis, Rheumatoid; Bursitis; Drug Evaluation; Female; Gastrointestinal Diseases; Hu

1978
Pharmacokinetic and therapeutic effects of ketoprofen.
    Il Farmaco; edizione pratica, 1978, Volume: 33, Issue:10

    Topics: Administration, Oral; Arthritis, Rheumatoid; Drug Evaluation; Gout; Humans; Injections, Intramuscula

1978
Long-term studies on therapy and tolerance of ketoprofen.
    Rheumatology and rehabilitation, 1979, Volume: Suppl

    Topics: Arthritis; Arthritis, Rheumatoid; Humans; Indomethacin; Ketoprofen; Kidney; Liver; Phenylpropionates

1979
The pharmacological properties of ketoprofen and its place in antirheumatic therapy.
    Rheumatology and rehabilitation, 1979, Volume: Suppl

    Topics: Analgesia; Animals; Arthritis, Rheumatoid; Body Temperature; Humans; Inflammation; Ketoprofen; Pheny

1979
The effect of clotrimazole on human lymphocyte responsiveness to plant mitogens.
    Agents and actions, 1979, Volume: 9, Issue:5-6

    Topics: Arthritis, Rheumatoid; Clotrimazole; Concanavalin A; Humans; Imidazoles; In Vitro Techniques; Ketopr

1979
A study of ketoprofen (Orudis) in the treatment of rheumatoid arthritis and osteoarthrosis.
    JPMA. The Journal of the Pakistan Medical Association, 1976, Volume: 26, Issue:10

    Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Benzophenones; Female; Humans; Ketoprofen; Male; Mid

1976
Synovial-fluid pharmacokinetics of ketoprofen.
    Rheumatology and rehabilitation, 1976, Volume: Suppl

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Benzophenones; Female; Humans; Ketoprofen; Male; Sy

1976
[Effect of antirheumatic agents on DNA-systems and DNA repair of various cell systems].
    Verhandlungen der Deutschen Gesellschaft fur Rheumatologie, 1976, Volume: 4

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; DNA; DNA Repair; Flufenamic Acid; Humans; In Vitro

1976
Sensible prescribing. The treatment of rheumatoid arthritis.
    The Practitioner, 1975, Volume: 215, Issue:1286

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Arthroplast

1975
[Injectable formulation of Rofenid. Clinical efficience of a new parenteral therapy in reumatology (author's transl)].
    Journal belge de rhumatologie et de medecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde, 1976, Volume: 31 Suppl

    Topics: Arthritis, Rheumatoid; Female; Humans; Injections; Ketoprofen; Male; Phenylpropionates; Rheumatic Di

1976
[Review of the clinical studies in rheumatoid arthritis with several non steroid anti-inflammatory agents (author's transl)].
    Journal belge de rhumatologie et de medecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde, 1975, Volume: 30 Spec no

    Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Drug Evaluation; Humans; Indomethacin; Ketoprofen;

1975
[The effect of so-called basic therapeutics and symptomatically effective antirheumatic drugs on the enzymes of DNA synthesis and DNA repair].
    Acta medica Austriaca, 1975, Volume: 2, Issue:4

    Topics: Apazone; Arthritis, Rheumatoid; Chloroquine; Cyclophosphamide; DNA; DNA Repair; Gold; Humans; Ketopr

1975
Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: I. Nonsteroidal antiinflammatory drugs.
    The Journal of rheumatology, 1992, Volume: 19, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Female; Humans; Indomethaci

1992
Long term study of ketoprofen SR in elderly patients.
    Scandinavian journal of rheumatology. Supplement, 1989, Volume: 83

    Topics: Aged; Arthritis, Rheumatoid; Delayed-Action Preparations; Female; Gastrointestinal Diseases; Humans;

1989
Clinical experience with ketoprofen in the management of osteoarthritis and rheumatoid arthritis.
    Maryland medical journal (Baltimore, Md. : 1985), 1989, Volume: 38, Issue:6

    Topics: Aged; Arthritis, Rheumatoid; Female; Humans; Ketoprofen; Male; Middle Aged; Osteoarthritis; Phenylpr

1989
Controlled-release ketoprofen in rheumatoid arthritis and osteoarthritis: comparison of two doses in Thailand.
    Clinical therapeutics, 1988, Volume: 10, Issue:3

    Topics: Acetaminophen; Adult; Aged; Arthritis, Rheumatoid; Delayed-Action Preparations; Female; Humans; Keto

1988
[Different effects of diclofenac and ketoprofen on the bactericidal action of polynuclear neutrophils in rheumatoid polyarthritis].
    Revue du rhumatisme et des maladies osteo-articulaires, 1987, Volume: 54, Issue:4

    Topics: Arthritis, Rheumatoid; Blood Bactericidal Activity; Diclofenac; Humans; Ketoprofen; Neutrophils; Phe

1987
Ketoprofen.
    The Medical letter on drugs and therapeutics, 1986, Jun-20, Volume: 28, Issue:716

    Topics: Arthritis; Arthritis, Rheumatoid; Drug Interactions; Humans; Ketoprofen; Kinetics; Osteoarthritis; P

1986
Acute and chronic pharmacokinetic studies of slow release ketoprofen (Oruvail) in rheumatoid arthritis.
    Clinical and experimental pharmacology & physiology, 1986, Volume: 13, Issue:7

    Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Body Burden; D

1986